Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC label warnings preceding active ingredients preferred in N.C. State study.

This article was originally published in The Tan Sheet

Executive Summary

OTC LABEL WARNINGS PRECEDING ACTIVE INGREDIENTS PREFERRED IN STUDY of 140 participants conducted by researchers at North Carolina State University. Led by Michael Wogalter, PhD, and William Vigilante, the study found that "in general, people prefer labels to first provide what the drug is used for (indications), second, provide information on associated hazards (warnings, cautions, drug interaction precautions) and use (directions), and third, provide information on active ingredients."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel